These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36210658)

  • 21. Lymph Node and Distant Metastases in Phyllodes Tumor of the Breast.
    Naal T; Saker S; Coldren D
    Int J Surg Pathol; 2023 Aug; 31(5):761-764. PubMed ID: 36285397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nodal Surgery for Patients ≥ 70 Undergoing Mastectomy for DCIS? Choose Wisely.
    Dalton EC; Chang C; Cardarelli C; Bleicher RJ; Aggon AA; Porpiglia AS; Pronovost MT; Williams AD
    Ann Surg Oncol; 2024 Oct; 31(11):7498-7507. PubMed ID: 38976159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coexisting invasive ductal carcinoma arising within a benign phyllodes tumour.
    Salem R; Wu F; Andaleeb U; Ahmed I
    BMJ Case Rep; 2024 Oct; 17(10):. PubMed ID: 39375162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
    Watanabe Y; Anan K; Saimura M; Koga K; Fujino M; Mine M; Tamiya S; Nishihara K; Nakano T; Mitsuyama S
    Breast Cancer; 2018 Nov; 25(6):663-670. PubMed ID: 29786772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Predictive factors of invasion with initial diagnosis of ductal carcinoma in situ based on core biopsy].
    Kósa C; Garami Z; Dinya T; Fülöp B
    Magy Seb; 2012 Aug; 65(4):218-21. PubMed ID: 22940391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ductal Carcinoma In Situ Simultaneously Involving the Breast and Epithelial Inclusions in an Ipsilateral Axillary Lymph Node.
    Commander LA; Ollila DW; O'Connor SM; Hertel JD; Calhoun BC
    Int J Surg Pathol; 2018 Sep; 26(6):564-568. PubMed ID: 29560779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
    Murthy V; Chamberlain RS
    Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Invasive Ductal Carcinoma within a Borderline Malignancy Phyllodes Tumor-A Case Report].
    Maeda N; Yu X; Nabeya M; Suyama R; Suzuki N; Takeda S; Tamesa M; Nagashima Y; Kubo H; Yamamoto S; Nagano H
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1618-1620. PubMed ID: 38303360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
    Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
    Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A Case of a Malignant Phyllodes Tumor in the Breast with Lymph Node Metastasis].
    Morisaki T; Noda S; Ishihara S; Asano Y; Kashiwagi S; Takashima T; Onoda N; Ohira M
    Gan To Kagaku Ryoho; 2021 Mar; 48(3):437-439. PubMed ID: 33790180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
    Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
    Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factor for axillary lymph node metastases in microinvasive breast cancer.
    Ko BS; Lim WS; Kim HJ; Yu JH; Lee JW; Kwan SB; Lee YM; Son BH; Gong GY; Ahn SH
    Ann Surg Oncol; 2012 Jan; 19(1):212-6. PubMed ID: 21633867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do not contemplate invasive surgery for ductal carcinoma in situ.
    Zelis JJ; Sickle-Santanello BJ; Liang WC; Nims TA
    Am J Surg; 2002 Oct; 184(4):348-9. PubMed ID: 12383899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary management.
    Sato Y; Kinoshita T; Suzuki J; Jimbo K; Asaga S; Hojo T; Yoshida M; Tsuda H
    Breast Cancer; 2016 Sep; 23(5):761-70. PubMed ID: 26324092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case report of a patient with ductal carcinoma and a malignant phyllodes tumor in situ in 2 separate breasts.
    Li C; Zhang C
    Medicine (Baltimore); 2023 Dec; 102(48):e36405. PubMed ID: 38050272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
    Shin YD; Lee HM; Choi YJ
    BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.